Takehiro Nakamura
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: University of Geneva (1992); University of Miyazaki (2009–2014); Scripps Research Institute (2008); Brigham and Women's Hospital (1995–2006); Fukushima Medical University (2024); Université Libre de Bruxelles (1994); Doshisha University (2006–2009); Harvard University (1995); Shinshu University (1994); Okayama University (2015); Meiji University (2019); Kumamoto Health Science University (2015); Shimane University (2008); Kyoto Prefectural University (2006); Kawasaki Medical School (2021–2024); Kyorin University (2011–2015); Kyushu Dental University (2005); Tohoku University (2019); Kagawa University (1998–2016); University of Michigan (2003–2008); Juntendo University (2019); Kyoto Prefectural University of Medicine (2002–2010); St. Luke's International Hospital (2006); Tohoku Agricultural Research Center (2009); Michigan Medicine (2006–2007); Meiji (Japan) (2019); Shimane Prefectural Central Hospital (2006); Kagawa University Hospital (1999–2009); Tokyo Women's Medical University (2005–2006); Kobe City Medical Center West Hospital (2023); RIKEN Center for Integrative Medical Sciences (2015); Neurological Surgery (2004); The Japan Stroke Association (2008); Omihachiman Community Medical Center (2012–2018); Asahino General Hospital (2015); The Japan Neurosurgical Society (2011); Nisshoku Corporation (Japan) (2005); National Defense Medical College (2010–2015); Kagawa Prefectural College of Health Sciences (2016–2020); The University of Texas at Austin (2006); Kumamoto University (1998)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Takehiro Nakamura's research has focused on the mechanisms and potential treatments for intracerebral hemorrhage and related neurological conditions. His work has investigated the role of iron and iron-handling proteins in brain injury following hemorrhage, examining how these elements contribute to oxidative stress and edema. Nakamura has also explored the therapeutic potential of compounds like deferoxamine and edaravone in mitigating the damaging effects of intracerebral hemorrhage in animal models.
Beyond his work on brain injury, Nakamura has contributed to studies on ocular surface disorders. He has been involved in research concerning the transplantation of cultivated oral mucosal epithelial cells for patients with severe ocular surface conditions, evaluating the long-term outcomes of these procedures. His publication record includes work on hepatocyte growth factor and its influence on urokinase-type plasminogen activator expression in epithelial cells.
Nakamura's scholarship metrics include an h-index of 41, with 234 total publications and 5,874 citations. He has collaborated with researchers at the University of Arkansas for Medical Sciences, including A. Montgomery, Raj Patel, Mary Rude, and Maikel Suárez Estrada.
Metrics
- h-index: 41
- Publications: 229
- Citations: 5,869
Selected Publications
-
Inferior Waitlist Outcomes Among Patients Listed for Simultaneous Liver-Kidney Transplantation (2025)
Collaboration Network
Top Collaborators
- Inferior Waitlist Outcomes Among Patients Listed for Simultaneous Liver-Kidney Transplantation
- Inferior Waitlist Outcomes Among Patients Listed for Simultaneous Liver-Kidney Transplantation
- Inferior Waitlist Outcomes Among Patients Listed for Simultaneous Liver-Kidney Transplantation
- Inferior Waitlist Outcomes Among Patients Listed for Simultaneous Liver-Kidney Transplantation
- Inferior Waitlist Outcomes Among Patients Listed for Simultaneous Liver-Kidney Transplantation
- Inferior Waitlist Outcomes Among Patients Listed for Simultaneous Liver-Kidney Transplantation
Similar Researchers
Based on overlapping research topics